Michael King
#1687 out of 1697 analysts
Rodman & Renshaw
Automatically Tracked
Analyst ratings are aggregated from multiple third-party sources and may be inaccurate, incomplete, or outdated. All ratings remain the sole responsibility of their original providers. Rankings are based on the 3-year performance of a simulated $100,000 account trading on analyst ratings data.
Gain and growth charts are calculated per selected timeframe:
-89.48%
Gain +7.73%
Monthly
-4.44%
Yearly
-42.03%
Drawdown
95.26%
$6,565.61
Equity
Holdings
$0
Cash
$6,565.61
Investment
$0
-$93,434.39
Profit +$472.72
Realized
-$93,434.39
Unrealized
$0
Dividends
$0
$6,565.61
Cash
Deposits
$100,000
Withdrawals
$0
Commissions
$0
Goals
Avg. 0% completed goals
Today
Compared To Yesterday
Gain
7.73%
Profit
$472.72
Win %
66%
This Week
Compared To Last Week
Gain
7.76%
Profit
$472.72
Win %
66%
This Month
Compared to last month
Gain
-17.93%
Profit
-$1,434.78
Win %
66%
This Year
Compared to last year
Gain
-28.93%
Profit
-$2,672.22
Win %
66%
REGN Regeneron Pharmaceuticals, Inc.
+$6,647.98
HOWL Werewolf Therapeutics, Inc.
+$4,169.9
JSPR Jasper Therapeutics Inc.
+$1,964.89
EXEL Exelixis Inc.
+$1,539.67
KPTI Karyopharm Therapeutics Inc.
+$314.93
APLM Apolomics Inc.
-$40,208.57
BMEA Biomea Fusion, Inc.
-$11,848.43
AGEN Agenus Inc.
-$9,858.57
AGIO Agios Pharmaceuticals Inc.
-$7,562.12
LTRN Lantern Pharma Inc.
-$6,800.49
XNCR Xencor Inc.
-$5,609.51
NTLA Intellia Therapeutics Inc.
-$5,338.23
COGT Cogent Biosciences, Inc.
-$3,833.95
OCEA Ocean Biomedical Inc.
-$3,738.67
ANAB AnaptysBio Inc.
-$3,649.35
DCOY Salarius Pharmaceuticals, Inc.
-$3,623.59
ELTX Elicio Therapeutics Inc.
-$2,324.15
CMPX Compass Therapeutics Inc.
-$1,997.09
VINC Vincerx Pharma Inc.
-$754.95
BTAI BioXcel Therapeutics, Inc.
-$663.01
ALNY Alnylam Pharmaceuticals Inc
-$261.08
Events
Loading...
Dividends
Dividend Analysis
Loading...
No Data
| Trades 363 | Longs Won 131/363 36% | Profit Factor 0.36 |
| Profitability | Shorts Won 0/0 0% | Standard Deviation $1,758.11 |
| Average Win $407.86 | Best Trade (Jan 30) $5,865.46 | Sharpe Ratio -218.56 |
| Average Loss -$633.03 | Worst Trade (Jul 10) -$25,807.22 | Z-Score -2.73 (100%) |
| Commissions $0 | Avg. Trade Length 2m 1w 1d | Expectancy -$257.4 |
| Loss Size | 100% | 90% | 80% | 70% | 60% | 50% | 40% | 30% | 20% | 10% |
| Probability of Loss | - | - | - | - | - | - | - | - | - | - |
| Consecutive Losing Trades | 10 | 9 | 8 | 7 | 6 | 5 | 4 | 3 | 2 | 1 |
Hover over the desired column for a detailed explanation.
Returns
Overall, Monthly| Symbol | Quantity | Cost | Value | Comm. | Profit ($) | Gain (%) | Change |
|---|
No Data
Option values are updated at end of day.
No Data
No Data
Option values are updated at end of day.
No Data
No Data
No Data
No Data
